United Kingdom· GB-APID-27947911000001104
Revestive 5mg powder and solvent for solution for injection vials
A teduglutide product containing teduglutide, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Teduglutide is registered in 15 of 19 countries.
Countries holding a registration under ATC A16AX08 (teduglutide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Teduglutide · ATC A16AX08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Teduglutide
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A16AX08
- ATC class
- Teduglutide
- Defined daily dose
- 5 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5060374860018
- gtin05060147025392
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for teduglutide.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Teduglutide · interactions on record
18 records
- 2 severe
- 16 moderate
Most severe, free to view
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- ClonazepamN03AE01moderate
- MidazolamN03AE02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Teduglutide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenNilleto 5 mg Pulver och vätska till injektionsvätska, lösningFresenius Kabi AB
- SpainREVESTIVE 5 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLETakeda Pharmaceuticals International Ag Ireland Branch
- IcelandRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- BelgiumRevestive 5 mgTakeda Pharmaceuticals International Ireland Branch
- PolandRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- SwitzerlandRevestive 5 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- NorwayRevestiveTakeda Pharmaceuticals International AG Ireland Branch
- FinlandRevestiveTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Tidonalle
- Spain · Teduglutida Cipla
- France · Téduglutide, Teduglutide Adalvo
- Iceland · Revestive, Teduglutide Viatris
- Liechtenstein · Revestive, Teduglutide Viatris
- Norway · Niletto, Revestive
- Sweden · Nilleto, Teduglutid Cipla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/777c3c6e-d82b-474e-97f6-3d7bd44f19e5 GET /v1/drugs/777c3c6e-d82b-474e-97f6-3d7bd44f19e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "27947911000001104",
"desc": "Revestive 5mg powder and solvent for solution for injection vials (Takeda UK Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "27947711000001101",
"source": "dmd",
"vtm_id": "777687003",
"strength": "5 mg",
"substance": "Teduglutide",
"ingredient": "Teduglutide",
"supplier_code": "3811601000001107"
}See everything about teduglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.